EHA Library - The official digital education library of European Hematology Association (EHA)

EPIDEMIOLOGY AND PROGNOSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES ADMITTED TO INTENSIVE CARE
Author(s): ,
regaieg haifa
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
,
Achour Bechir
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
,
bouslema emna
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
,
bouneb rania
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
,
ben youssef yosra
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
khelif abderrahim
Affiliations:
hematology,farhat hached hospital,sousse,Tunisia
(Abstract release date: 05/19/16) EHA Library. Haifa R. 06/09/16; 134801; PB1901
Dr. Regaieg Haifa
Dr. Regaieg Haifa
Contributions
Abstract
Abstract: PB1901

Type: Publication Only

Background
The hospitalisation in intensive care unit of a patient with malignant haematology constitutes   a difficult problem for haematology and intensive care teams. 

Aims
-carry out an assessment of activity of the medical intensive care unit of  Farhat HACHED   hospital in  Sousse.-studying demographic and haematological characteristics of these patients and their specific care in the ICU, mostly in terms of organ failure-study the short-term survival of the population-Finally, this study will attempt to identify prognostic factors for ICU mortality.

Methods
 Single retrospective study, in the medical intensive care unit of  Farhat Hached  hospital Sousse on 20 years (1994-2014).this study  included 105 patients with  haematological malignancies.

Results
During the study period, 6000 patients were hospitalized in the intensive care unit of which 105 (1.75%) had  hematologic malignancies. the median age of the study population was 49 years (15-86 years). the sex ratio was 1.56. the 2 most frequent haematological diseases  were  non-Hodgkin lymphoma  and acute myeloid leukaemia. 33,3% of patients were in the  diagnosis  stage; 51.4%  were  in relapse or progression stage  and 18.1% were  in complete remission. the median scores of  APACHE and SAPSII scores   were respectively 48 and 32. The reason for admission of patients was acute respiratory failure in nearly half the cases. The cause of acute respiratory failure was pneumonia in 54% and an acute oedema of the lungs in 35% of cases.  45% of patients were intubated and ventilated; the median duration of invasive mechanical ventilation was 2 days.27 patients had received non-invasive ventilation therapy (25.5%) at admission. forty two (40%) patients needed treatment with catecholamine’s. the median length of ICU stay was 4 days and the mortality rate in ICU was therefore 73.3%.Independent predictors factors of mortality in intensive care were severity at admission (score SAPSII) (p = 10-3), the use of invasive mechanical ventilation (p = 0.015), and the use of catecholamine’s (p = 0.038).

Conclusion
The short-term prognosis, according to this study, is exclusively predicted severity at admission, the use of invasive mechanical ventilation, and the use of catecholamines. According to recent data, discussion between haematologist and intensive care, the very early admitted patients and non invasive ventilation seem to improve survival.

Session topic: E-poster

Keyword(s): Salvage therapy
Abstract: PB1901

Type: Publication Only

Background
The hospitalisation in intensive care unit of a patient with malignant haematology constitutes   a difficult problem for haematology and intensive care teams. 

Aims
-carry out an assessment of activity of the medical intensive care unit of  Farhat HACHED   hospital in  Sousse.-studying demographic and haematological characteristics of these patients and their specific care in the ICU, mostly in terms of organ failure-study the short-term survival of the population-Finally, this study will attempt to identify prognostic factors for ICU mortality.

Methods
 Single retrospective study, in the medical intensive care unit of  Farhat Hached  hospital Sousse on 20 years (1994-2014).this study  included 105 patients with  haematological malignancies.

Results
During the study period, 6000 patients were hospitalized in the intensive care unit of which 105 (1.75%) had  hematologic malignancies. the median age of the study population was 49 years (15-86 years). the sex ratio was 1.56. the 2 most frequent haematological diseases  were  non-Hodgkin lymphoma  and acute myeloid leukaemia. 33,3% of patients were in the  diagnosis  stage; 51.4%  were  in relapse or progression stage  and 18.1% were  in complete remission. the median scores of  APACHE and SAPSII scores   were respectively 48 and 32. The reason for admission of patients was acute respiratory failure in nearly half the cases. The cause of acute respiratory failure was pneumonia in 54% and an acute oedema of the lungs in 35% of cases.  45% of patients were intubated and ventilated; the median duration of invasive mechanical ventilation was 2 days.27 patients had received non-invasive ventilation therapy (25.5%) at admission. forty two (40%) patients needed treatment with catecholamine’s. the median length of ICU stay was 4 days and the mortality rate in ICU was therefore 73.3%.Independent predictors factors of mortality in intensive care were severity at admission (score SAPSII) (p = 10-3), the use of invasive mechanical ventilation (p = 0.015), and the use of catecholamine’s (p = 0.038).

Conclusion
The short-term prognosis, according to this study, is exclusively predicted severity at admission, the use of invasive mechanical ventilation, and the use of catecholamines. According to recent data, discussion between haematologist and intensive care, the very early admitted patients and non invasive ventilation seem to improve survival.

Session topic: E-poster

Keyword(s): Salvage therapy

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies